Market revenue in 2022 | USD 6.3 million |
Market revenue in 2030 | USD 14.5 million |
Growth rate | 11% (CAGR from 2022 to 2030) |
Largest segment | Sperm separation device |
Fastest growing segment | Imaging System |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ovum Aspiration Pumps, Sperm Separation Device, Sperm Analyzer Systems, Micromanipulators Systems, Incubators, Cryosystems, Imaging System, Microscopes |
Key market players worldwide | The Cooper Companies Inc, Cook Medical, Vitrolife AB ADR, Eppendorf, AB Science, Hamilton Thorne Ltd, Rocket Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infertility treatment devices and equipment market will help companies and investors design strategic landscapes.
Sperm separation device was the largest segment with a revenue share of 17.46% in 2022. Horizon Databook has segmented the Australia infertility treatment devices and equipment market based on ovum aspiration pumps, sperm separation device, sperm analyzer systems, micromanipulators systems, incubators, cryosystems, imaging system, microscopes covering the revenue growth of each sub-segment from 2018 to 2030.
Australia made significant technological advancements in ART. Examples are Preimplantation Genetic Diagnosis (PGD) and Preimplantation Genetic Screening (PGS), which are used to screen embryos for genetic disorders before implantation.
Another example is the development of time-lapse imaging technology, which allows continuous monitoring of embryos without disrupting the culture environment. This technology provides more information about embryo development and helps improve success rates in ART.
This may further boost the market growth. For instance, in January 2022, Fertilize raised USD 2 million to automate IVF embryo culturing to make IVF less stressful and more successful for patients and clinicians.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia infertility treatment devices and equipment market , including forecasts for subscribers. This country databook contains high-level insights into Australia infertility treatment devices and equipment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account